Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

EM VivasCommunity-acquired pneumonia

EM Vivas · Community-acquired pneumonia

Community-acquired pneumonia — the severity and the empiric antibiotics

A clinical viva on the CURB-65 and the severity-stratified antibiotics.

clinical1 min readSource-verified ·

Target exams

ACEMFRCEMABEM
On this page
Study tools

Target exams

ACEMFRCEMABEM
Prompt
Describe the CURB-65 severity score and how it drives the site of care, and the empiric antibiotic regimen by the severity.

Interpretation

Reveal interpretationShowHide

The CURB-65 score (the five criteria):

  • Confusion — the new disorientation.
  • Urea raised — above 7 mmol/L.
  • Respiratory rate — 30 or above.
  • Blood pressure — the systolic below 90 or the diastolic 60 or below.
  • 65 — the age 65 or above.
  • Each criterion is the one point.
  • 0 to 1 — NICE: consider home-based care (low risk, under 3 percent 30-day mortality).
  • 2 — consider hospital-based care (intermediate, 3 to 15 percent). Lim's exact score-2 mortality is 3 percent.
  • 3 or above — consider intensive-care assessment (high risk, over 15 percent). Not automatic ICU and not an automatic hour-1 antibiotic unless there is shock.[1][3]

Empiric antibiotics (ATS/IDSA 2019; local eTG for the ANZ product):

  • Healthy outpatient — amoxicillin 1 g three times daily or doxycycline 100 mg twice daily or a macrolide if pneumococcal macrolide resistance is under 25 percent (not automatically amoxicillin plus a second agent).
  • Inpatient non-severe — beta-lactam plus macrolide or a respiratory fluoroquinolone.
  • Severe — beta-lactam plus macrolide or beta-lactam plus fluoroquinolone. MRSA/Pseudomonas only with locally validated risk factors. HCAP is abandoned.[2]

Principles: CURB-65 plus judgement; atypical cover in hospitalised CAP; Legionella clues are hyponatraemia, GI and neurological features (not LDH as a rule); cultures must not delay the first dose; duration minimum 5 days plus clinical stability, not a default 14-day Legionella course.[2][1]

Emergency Medicine Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Emergency Medicine fellowship library.

Sign in to continueSee pricing
References3ShowHide
  1. [1]Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 2003.PMID 12728155
  2. [2]Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med, 2019.PMID 31573350
  3. [3]National Institute for Health and Care Excellence Pneumonia in adults: diagnosis and management (CG191) NICE, 2014.Source
Emergency Medicine Pro

$29/ monthor $279 / year

The complete Emergency Medicine library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousChronic salicylism and intubation riskSalicylate poisoningNextCompartment syndrome after backslabSplinting and immobilisation